Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
3.78 USD
0.53%
Market Closed
Updated:
May 5, 2024
Chromadex Corp
Gross Profit
|
Chromadex Corp
Gross Profit Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Gross Profit
$50.8m
|
CAGR 3-Years
13%
|
CAGR 5-Years
26%
|
CAGR 10-Years
32%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Gross Profit
$17.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
|
Danaher Corp
NYSE:DHR
|
Gross Profit
$25.6B
|
CAGR 3-Years
21%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Gross Profit
$2.2B
|
CAGR 3-Years
8%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Gross Profit
$3.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Gross Profit
$5.2B
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
15%
|
See Also
What is Chromadex Corp's Gross Profit?
Gross Profit
50.8m
USD
50.8m
USD
Based on the financial report for Dec 31, 2023, Chromadex Corp's Gross Profit amounts to 50.8m USD.
What is Chromadex Corp's Gross Profit growth rate?
Gross Profit CAGR 10Y
32%
32%
Over the last year, the Gross Profit growth was 19%. The average annual Gross Profit growth rates for Chromadex Corp have been 13% over the past three years , 26% over the past five years , and 32% over the past ten years .
You don't have any saved screeners yet
